How to Help Your Patients Save Money on Exemestane: A Provider's Guide to Savings Programs

Medication cost is one of the most underappreciated drivers of non-adherence in breast cancer hormonal therapy. A patient who cannot afford to fill their exemestane prescription — or who rations doses to make a 30-day supply last 60 days — is not receiving the protective benefit that makes adjuvant hormonal therapy so valuable. This guide equips you with every cost-reduction tool available in 2026 so you can proactively support your patients before cost becomes a barrier.

Why Exemestane Costs More Than Anastrozole or Letrozole

Generic anastrozole and letrozole are among the least expensive generics in oncology — often available for under $6 per month with discount coupons. Generic exemestane is more expensive, with retail prices ranging from approximately $37 to over $500 per 30-day supply depending on pharmacy, and coupon prices typically in the $25–$36 range.

The higher cost reflects exemestane's lower prescription volume (smaller market) and its unique mechanism as the only steroidal aromatase inhibitor. Fewer competing generic manufacturers means less downward price pressure compared to anastrozole or letrozole. This price differential can be meaningful for patients on fixed incomes or with high-deductible plans.

The True Cost of Non-Adherence

Before focusing on solutions, it's worth framing the clinical stakes. Adjuvant hormonal therapy for ER-positive breast cancer reduces the risk of recurrence by approximately 40–50% compared to no endocrine therapy. The Intergroup Exemestane Study demonstrated that switching from tamoxifen to exemestane after 2–3 years significantly improved disease-free survival. Non-adherence to AI therapy — driven largely by side effects and cost — is associated with worse outcomes. A patient who cannot afford exemestane needs access to cost reduction tools, not a medication switch driven by financial barriers alone.

Tool 1: GoodRx and SingleCare — Instant Savings with No Application Required

For patients without insurance or with high copays, GoodRx and SingleCare can immediately reduce exemestane costs with no application, no eligibility verification, and no wait:

• GoodRx: Generic exemestane available for approximately $25–$36 per 30-day supply at participating pharmacies. GoodRx Companion membership further reduces this price. Access at GoodRx.com or the GoodRx app.
• SingleCare: Comparable savings — approximately $29 per 30-day supply at participating pharmacies. Available at SingleCare.com.

Important guidance for patients: GoodRx and SingleCare cannot be used with insurance simultaneously. Advise patients to compare their insurance copay against the GoodRx or SingleCare price — and use whichever is lower.

Tool 2: Good Days Patient Assistance Program

The Good Days Patient Assistance Program is specifically designed for insured patients who are struggling with copay or coinsurance costs for exemestane:

• Phone: 1-877-968-7233
• Website: mygooddays.org
• Eligibility requirements: Must have valid insurance and a valid prescription; income and other eligibility criteria apply

Your practice's oncology social worker or patient navigator can help patients initiate the application. Building this referral into your standard intake workflow can proactively prevent cost-driven adherence gaps.

37,512+ patients found their medications in stock

37K+

Find Exemestane In Stock Today →

Tool 3: NeedyMeds and RxAssist — Comprehensive Assistance Databases

These nonprofit databases compile all available patient assistance programs by medication:

• NeedyMeds.org: Searchable database of manufacturer PAPs, state programs, disease-specific programs, and drug coupons. Also includes a drug discount card.
• RxAssist.org: Designed specifically for healthcare providers. Search by drug name to find all active assistance programs, eligibility criteria, and application instructions.

Tool 4: Mail-Order Pharmacy — Cost and Access in One

Prescribing a 90-day supply through a mail-order pharmacy simultaneously reduces cost per tablet and eliminates the retail pharmacy stock problem. Mail-order pharmacies (CVS Caremark, Express Scripts, Optum Rx, Amazon Pharmacy) stock exemestane reliably and typically offer 90-day supplies at the cost of about two 30-day supplies — effectively a 33% discount.

For patients whose insurance requires mail-order for maintenance medications (increasingly common among commercial payers), this can reduce out-of-pocket costs significantly. Write 90-day prescriptions for all stable patients on exemestane.

Skip the calls, skip the stress.

Find Exemestane In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Tool 5: Prior Authorization Optimization

Some commercial and Medicare Part D plans require prior authorization for exemestane, particularly when step therapy (trying anastrozole or letrozole first) is required. Denials generate patient cost and adherence risk. Proactive PA submission with complete documentation can prevent these delays:

• Submit PA preemptively for new patients (don't wait for a denial)
• Include ER-positive diagnosis, postmenopausal status, prior AI use and outcomes, and specific clinical rationale for exemestane if applicable
• Request peer-to-peer review immediately upon denial — success rates for peer-to-peer appeals are substantially higher than initial PA approval rates
• For Medicare patients on high-cost Part D plans, compare plan formularies at plan open enrollment — some plans cover exemestane on lower tiers than others

Medicare-Specific Savings for Exemestane

Medicare Part D covers exemestane, but copays vary widely by plan. Key 2026 Medicare updates relevant to exemestane patients:

• The 2026 Part D annual out-of-pocket cap is $2,100 — patients who reach this threshold pay nothing for the rest of the year
• Patients with low income may qualify for Extra Help (Low Income Subsidy), which dramatically reduces Part D copays for Medicare beneficiaries — as low as $0–$10 per month
• Advise patients to use Medicare.gov's plan finder tool at annual open enrollment to find Part D plans with the best formulary coverage for exemestane

Building Cost Screening into Your Practice Workflow

The most effective approach is proactive: screen for financial barriers at the time exemestane is first prescribed, not after the patient has already missed doses. Consider adding the following to your standard initiation workflow:

1. Ask about insurance coverage type (commercial, Medicare, Medicaid, uninsured) at prescription initiation
2. For uninsured patients: immediately provide a GoodRx or SingleCare coupon printout
3. For insured patients with high copays: refer to Good Days Patient Assistance or your oncology social worker
4. For Medicare patients: check Extra Help eligibility and suggest plan review at next open enrollment
5. Write 90-day mail-order prescriptions for all stable patients

Additional Provider Resources

For help with pharmacy access — not just cost — visit medfinder.com/providers to learn how medfinder supports patients who are struggling to find exemestane in stock at their pharmacies. Also see our guide How to Help Your Patients Find Exemestane in Stock for a full pharmacy navigation protocol.